Court Place Advisors LLC Has $1.44 Million Position in CVS Health Co. (NYSE:CVS)

Court Place Advisors LLC cut its position in shares of CVS Health Co. (NYSE:CVS) by 29.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 32,105 shares of the pharmacy operator’s stock after selling 13,595 shares during the period. Court Place Advisors LLC’s holdings in CVS Health were worth $1,441,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Ascent Group LLC increased its holdings in shares of CVS Health by 14.6% during the 2nd quarter. Ascent Group LLC now owns 20,188 shares of the pharmacy operator’s stock worth $1,192,000 after acquiring an additional 2,578 shares during the last quarter. Magnolia Capital Advisors LLC acquired a new stake in shares of CVS Health in the second quarter valued at approximately $795,000. William B. Walkup & Associates Inc. bought a new stake in shares of CVS Health during the 2nd quarter valued at $1,269,000. Wallace Advisory Group LLC bought a new stake in CVS Health during the second quarter worth about $457,000. Finally, Regal Investment Advisors LLC lifted its holdings in shares of CVS Health by 16.4% during the 2nd quarter. Regal Investment Advisors LLC now owns 82,350 shares of the pharmacy operator’s stock worth $4,864,000 after acquiring an additional 11,617 shares during the period. 80.66% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms have weighed in on CVS. UBS Group upped their target price on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Evercore ISI boosted their target price on CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Monday. Royal Bank of Canada reduced their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $68.12.

CVS Health Stock Up 3.0 %

Shares of NYSE CVS opened at $56.20 on Tuesday. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The company’s 50 day moving average price is $51.24 and its 200-day moving average price is $56.20. The company has a market capitalization of $70.72 billion, a P/E ratio of 14.26, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.21 earnings per share. Equities analysts forecast that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.73%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.